A new study published by the Alzheimer's Association has found that measuring biological age through blood metabolites may help predict an individual's risk of developing dementia.

The research suggests that biological age, as distinct from chronological age, can be determined through analysis of specific compounds found in blood samples. These metabolites appear to serve as indicators of how the body is aging at a cellular level.

According to the study findings, individuals whose biological age exceeds their chronological age showed increased risk for all-cause dementia. The research adds to growing evidence that biological markers in blood may serve as early warning signs for cognitive decline.

The study represents part of ongoing efforts to develop better screening tools for dementia risk assessment. Current methods for predicting dementia often rely on cognitive tests and brain imaging, which may not detect early changes in brain health.

The Alzheimer's Association published the research as part of its ongoing investigation into risk factors and early detection methods for dementia. The findings could potentially lead to new screening protocols that allow for earlier intervention and treatment planning.